M&A Deal Summary |
|
|---|---|
| Date | 2013-11-13 |
| Target | CRI Lifetree |
| Sector | Healthcare Services |
| Buyer(s) | PRA Health Sciences |
| Sellers(s) | Ampersand Capital Partners |
| Deal Type | Add-on Acquisition |
SEARCH BY
Try For Free 7-Day Free Trial
| Category | Company |
|---|---|
| Founded | 1976 |
| Sector | Life Science |
| Employees | 17,500 |
| Revenue | 3.1B USD (2019) |
PRA Health Sciences, Inc. is an international clinical research organization. PRA provides services on a contract basis to the pharmaceutical and biotechnology industries. Comprehensive services include the filing of Investigational New Drug (IND) and similar regulatory applications, management and implementation of Phase I through IV clinical trials, preparation and submission of New Drug Applications (NDAs), and post-marketing surveillance on an international basis. PRA was formed in 1976 and is based in Raleigh, North Carolina.
| DEAL STATS | # |
|---|---|
| Overall | 6 of 8 |
| Sector (Healthcare Services) | 2 of 2 |
| Type (Add-on Acquisition) | 6 of 8 |
| State (New Jersey) | 1 of 1 |
| Country (United States) | 3 of 5 |
| Year (2013) | 3 of 3 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2013-07-31 |
ReSearch Pharmaceutical Services
Fort Washington, Pennsylvania, United States ReSearch Pharmaceutical Services, Inc. is a provider of integrated global clinical development solutions to the bio-pharmaceutical industry based on its comprehensive therapeutic expertise, robust clinical operations infrastructure, and highly trained and experienced employee base. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2017-08-07 |
Symphony Health Solutions
Phoenix, Arizona, United States Symphony Health Solutions Corp. is a provider of data, applications, analytics and consulting to help life sciences companies gain deeper insights into the pharmaceutical market. Symphony Health Solutions Corp. was established in 2012 and is based in Phoenix, Arizona. |
Buy | - |
| Category | Growth Capital Firm |
|---|---|
| Founded | 1988 |
| PE ASSETS | 3.0B USD |
| Size | Large |
| Type | Sector Focused |
Ampersand Capital Partners is a middle-market private equity group that concentrates on growth equity investment opportunities in the healthcare sector. The Firm looks to invest $10 to $100 million in businesses with $10 to $100 million of revenue. Specific areas of interests within healthcare include lab products, specialty diagnostic equipment, pharmaceutical outsourcing, and specialty pharma. Ampersand generally prefers to be the first and sole institutional investor. Ampersand was formed in 1988 and is based in Wellesley, Massachusetts.
| DEAL STATS | # |
|---|---|
| Overall | 20 of 55 |
| Sector (Healthcare Services) | 1 of 3 |
| Type (Add-on Acquisition) | 14 of 38 |
| State (New Jersey) | 3 of 5 |
| Country (United States) | 20 of 51 |
| Year (2013) | 2 of 2 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2013-03-15 |
CoreLab Partners
Princeton, New Jersey, United States CoreLab Partners, Inc. is a provider of linical trials, medical image assessment, and cardiac safety solutions. |
Sell | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2014-01-01 |
Elite One Source Nutrisciences
Chino, California, United States Elite One Source Nutrisciences is a contract manufacturer for nutritional and dietary supplements. The business draws on world class facilities across two locations and a deep and experienced team of formulators, chemists, natural product specialists, and particle engineers. |
Buy | - |
